<code id='E14F073623'></code><style id='E14F073623'></style>
    • <acronym id='E14F073623'></acronym>
      <center id='E14F073623'><center id='E14F073623'><tfoot id='E14F073623'></tfoot></center><abbr id='E14F073623'><dir id='E14F073623'><tfoot id='E14F073623'></tfoot><noframes id='E14F073623'>

    • <optgroup id='E14F073623'><strike id='E14F073623'><sup id='E14F073623'></sup></strike><code id='E14F073623'></code></optgroup>
        1. <b id='E14F073623'><label id='E14F073623'><select id='E14F073623'><dt id='E14F073623'><span id='E14F073623'></span></dt></select></label></b><u id='E14F073623'></u>
          <i id='E14F073623'><strike id='E14F073623'><tt id='E14F073623'><pre id='E14F073623'></pre></tt></strike></i>

          Home / explore / hotspot

          hotspot


          hotspot

          author:entertainment    Page View:646
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In